One of the most extensively studied biomarkers is PCA3—an lncRNA whose level in urinary EVs can differentiate between healthy men and PCa patients (Motamedinia et al., 2016), and between PCa patients with GS ≤ 6 vs. The gene discussed is PCA3; the disease is posterior cortical atrophy.